There is no doubt about the fact that a sizeable chunk of the world population has been touched by the Internet and that people have now gone online for most things like shopping, medical help and even raising funds for start-ups. While this is definitely a positive step in terms of technology advancement, this shift to the online world has done reasonable damage to the offline retail industry comprising of huge retail chains like Wal-Mart (WMT), Target Corp (TGT) and Costco (COST). However, Costco has been above the rest in terms of delivering consistent results because of its robust membership model, high employee morale and effective cost management.
Reasonable Numbers
For the second quarter of 2014, Costco's earnings slid to $1.05 per share from $1.24 per share, a year ago. Though the company's last year earnings were impacted by a $52 million or $0.14 per share tax benefit, the current earnings are still a few notches below the prior-year period. Sales were up by approximately 6% in quarter two on an overall basis and 3% on a comp basis. As management pointed out, the four-week period between Thanksgiving and Christmas saw weak sales as compared to the previous year mainly because of a snowy weather prevalent at that time.
Top 5 Financial Stocks To Own For 2015: Hatteras Financial Corp (HTS)
Hatteras Financial Corp., incorporated on September 19, 2007, is an externally managed mortgage real estate investment trust (REIT) that invests primarily in single-family residential mortgage pass-through securities guaranteed or issued by the United States Government agency (such as the Government National Mortgage Association (Ginnie Mae)), or by the United States Government-sponsored entity (such as the Federal National Mortgage Association, (Fannie Mae)), and the Federal Home Loan Mortgage Corporation, (Freddie Mac)). The Company is externally managed and advised by its manager, Atlantic Capital Advisors LLC.
The Company focuses on agency securities consisting of mortgage loans with short durations. The agency securities consist of mortgages that have principal and interest payments guaranteed by Ginnie Mae, Fannie Mae or Freddie Mac. It invests in both fixed-rate and adjustable-rate agency securities. Adjustable rate mortgages (ARMs) are mortgages that have floating interest rates that reset on a specific time schedule, such as monthly, quarterly or annually, based on a specified index, such as the 12-month moving average of the one-year constant maturity United States Treasury rate (CMT) or the London Interbank Offered Rate (LIBOR). The ARMs it generally invests in, sometimes referred to as hybrid ARMS, have interest rates that are fixed for an initial period (typically three, five, seven or 10 years) and then reset annually thereafter to an increment over a pre-determined interest rate index.
Advisors' Opinion:- [By Amanda Alix]
More mREITs stay the course, but two trim payouts
Despite suffering many tumbles and bruises, several mREITs have announced that their dividends will be unchanged from the previous quarter. Several did so last week, and yesterday saw Hatteras Financial (NYSE: HTS ) , an agency-only trust, keeping its own $0.70 per share�payout the same. Hybrid New York Mortgage Trust (NASDAQ: NYMT ) also kept its dividend stable, at $0.27 per share, in line with its four most recent distributions. - [By Zain Zafar]
Hatteras Financial (NYSE: HTS ) �was one of the worst performers during the period despite following a relatively conservative strategy of investing mostly in adjustable-rate mortgage (ARM) mortgage-backed securities, as opposed to fixed-rate 30-year MBSes that can often carry a larger interest rate risk.�
- [By Rich Duprey]
Single-family-housing REIT�Hatteras Financial (NYSE: HTS ) announced yesterday its second-quarter dividend of $0.70 per share, the same rate it's paid for the past two quarters after cutting the payout 12.5% from $0.80 per share.
- [By Amanda Alix]
A great year for mortgage REITs
American Capital Agency went public in 2008, a year that saw other mREITs such as Hatteras Financial� (NYSE: HTS ) , and Armour Residential� (NYSE: ARR ) enter the territory as well. Groundbreaker Annaly had shown that the carry trade could be lucrative, and the ultra-low short-term interest rate environment created a perfect climate for new companies to enter the playing field.
Top 5 Up And Coming Companies To Invest In 2014: Rayonier Inc. REIT(RYN)
Rayonier, Inc. engages in the sale and development of real estate and timberland management, as well as in the production and sale of cellulose fibers in the United States, New Zealand, and Australia. The company operates in four segments: Timber, Real Estate, Performance Fibers, and Wood Products. Timber segment owns, leases, or manages timberlands and sells standing timber at auction to third parties, as well as sells delivered logs. Real Estate segment sells medium and large tracts of land with infrastructure. This segment holds development and rural properties primarily in the southeast United States. Performance Fibers segment manufactures cellulose specialties that are used principally in acetate textile fibers, cigarette filters, rigid packaging, LCD screens, photographic film, impact-resistant plastics, high-tenacity rayon yarn, pharmaceuticals, cosmetics, detergents, food casings, and food products; and absorbent materials that are used in disposable baby diapers, feminine hygiene products, incontinence pads, convalescent bed pads, industrial towels and wipes, and nonwoven fabrics. Wood Products segment primarily manufactures and sells dimension lumber used for residential and industrial construction applications. In addition, Rayonier involves in trading and exporting logs, lumber, and wood panel products. As of December 31, 2005, it owned, leased, or managed approximately 2.5 million acres of timberland and real estate. The company has a joint venture with RREEF Infrastructure to own and manage timber lands in New Zealand. Rayonier has elected to be treated as a real estate investment trust (REIT) for federal income tax purposes and would not be subject to federal income tax on its REIT income that it distributes to its shareholders. The company, formerly known as Rainier Pulp & Paper Company, was founded in 1926. Rayonier is headquartered in Jacksonville, Florida.
Advisors' Opinion:- [By Jake L'Ecuyer]
Rayonier (NYSE: RYN) was also up, gaining 6.78 percent to $43.97 after the company reported Q4 results and announced its plans to separate into two public companies.
- [By MONEYMORNING]
Most investors don't think of Rayonier Inc. (NYSE: RYN) as a high-tech firm.
This 85-year-old forest products company operates as a Real Estate Investment Trust (REIT) after being first acquired, then later spun off, by ITT Corp. (NYSE: ITT).
- [By Dan Caplinger]
Even with those unfavorable conditions, though, fellow forest-products REIT Rayonier (NYSE: RYN ) reported second-quarter sales that more than doubled from year-ago levels thanks to the company's boost in ownership of a joint venture in New Zealand from 26% to 65%. Even excluding those effects, higher sawlog demand in its Gulf of Mexico region and strong export demand for its Pacific Northwest products offset higher logging costs. Those gains were much healthier than what Rayonier experienced in its performance-fibers division, but the company expects to exit the higher-cost portion of that business segment. Rayonier's results set the stage for similar performance from Plum Creek.
- [By Shauna O'Brien]
Shares of Rayonier Inc. (RYN) were up over 11% on Monday morning after the company reported earnings above analysts’ estimates.�
RYN’s Earnings in Brief
RYN reported earnings of $80 million, or 62 cents per share, up from $76 million, or 59 cents per share a year ago. Revenue for the quarter was�$520.2 million, �above analysts’ estimate of $442.36 million. FY2013 earnings were�$372 million, or $2.86 per share, compared to $279 million, or $2.17 per share last year. RYN also announced that it now plans to separate its��from its Forest Resources and Real Estate business. The spin off will result in two separate publicly traded companiesCEO Commentary
Paul Boynton, Chairman, President and CEO commented:�”As part of our strategic planning process, we began in-depth analysis and preparation for the business separation almost two years ago. With an improving U.S. housing market, strong timber export markets, and the successful expansion of our cellulose specialties capacity, we concluded that now is the optimal time to pursue the separation of these two non-integrated businesses.”
�RYN’s Dividend
RYN paid its last quarterly dividend of 49 cents on December 31. The company is expected to declare its next dividend sometime in February.
Stock Performance�
Rayonier shares were up $4.57, or 11.10% during pre-market trading Monday. The stock is down 2% YTD.
Top 5 Up And Coming Companies To Invest In 2014: RadNet Inc.(RDNT)
RadNet, Inc. provides outpatient diagnostic imaging services in the United States. The company offers various imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures. It also provides teleradiology services to radiology groups, hospitals, and imaging centers. In addition, the company offers picture archiving and communications systems and related workflow solutions for hospitals, teleradiology businesses, imaging centers, and specialty physician groups to distribute, visualize, store, and retrieve digital images taken from various diagnostic imaging modalities. As of December 31, 2011, it operated 233 diagnostic imaging facilities in California, Delaware, Maryland, New Jersey, Rhode Island, Florida, and New York. RadNet, Inc. was founded in 1985 and is headquartered in Los Angeles, California.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
Alamy There are plenty of stocks going up -- and down -- in any given week. The gainers inspire us to keep investing. The decliners keep greed in check while reminding us about the risks of the equity markets. Let's go over some of last week's best and worst performers. Pike (PIKE) -- Up 49 percent last week The market's biggest winner of last week was Pike, a specialty construction and engineering firm that received a bid to be taken private. J. Eric Pike -- the firm's chairman and CEO -- is teaming up with private equity firm Court Square Capital Partners to buy out shareholders at $12 a share. It's a fair premium, pricing the buyout at a better than 50 percent premium to where the stock was trading when it was announced. A few attorneys are trying to smoke out investors who feel that the CEO-led privatization push isn't fair, but it's likely to stick at that kind of healthy markup. Pike shares may have traded in the low teens last summer, but that was before revenue and earnings began heading the wrong way. Most shareholders should be more than happy to take the money and run. RadNet (RDNT) -- Up 34 percent last week Operating a network of 251 facilities that perform outpatient diagnostic imaging services is looking good for RadNet. The stock moved sharply higher after a strong quarterly report. Revenue inched slighting higher as MRI and CT scan volume increased modestly during the period. However, the real star in the report was RadNet's bottom line. Its cost-cutting and debt-slashing efforts paid off with net income soaring to $0.12 a share after clocking in at a $0.07 a share a year earlier. Analysts were only holding out for $0.05 a share. RadNet also helped improve its standing by boosting its guidance for all of 2014. You don't need any of RadNet's fancy imaging equipment to see that that's a healthy sign. Trex (TREX) -- Up 25 percent last week It was a good week for a pair of home improvement specialists. Shares of CaesarStone (CSTE) moved 20
Top 5 Up And Coming Companies To Invest In 2014: Cytori Therapeutics Inc(CYTX)
Cytori Therapeutics, Inc. engages in the development, manufacture, and sale of medical products and devices to enable the practice of regenerative medicine. Regenerative medicines focus on repairing or restoring lost or damaged tissue and cell function. Its principal products include the Celution family of products, which processes patients' adipose-derived stem and regenerative cells (ADRCs) at the point of care. The Celution family of products consists of a central device, a related single-use consumable used for each patient procedure, proprietary enzyme reagents, and related instrumentation. Its core product, the Celution System, provides physicians with clinical grade stem and regenerative cells for use in the cosmetic and reconstructive surgery market. The company also provides PureGraft, a consumable product that provides grafts for use in aesthetic body contouring procedures. In addition, it sells the StemSource family of products worldwide, including in the United States, for research, as well as for the cryopreservation and storage of ADRCs. It offers the StemSource System as a standalone product, or as a part of a comprehensive suite of systems, equipment, and protocols collectively referred to as a StemSource Cell Bank. Further, the company develops Celution System, which has completed two clinical trials for applications in cardiovascular disease, wound healing, gastrointestinal disorders, stress urinary incontinence, liver and renal disease, spinal disc degeneration, and pelvic health conditions. It has strategic development and manufacturing joint venture agreement, and other related agreements with Olympus Corporation. The company was formerly known as MacroPore Biosurgery, Inc. Cytori Therapeutics, Inc. was founded in 1996 and is headquartered in San Diego, California.
Advisors' Opinion:- [By James E. Brumley]
If you're reading this, then odds are you already know that Cytori Therapeutics Inc. (NASDAQ:CYTX) is up a whopping 8% today. In some ways that's encouraging, as it proves there's a lot of trade-worthy momentum to be tapped. In other ways, however, it's bad, because CYTX is overbought and ripe for a pullback. No matter how you're seeing Cytori Therapeutics in the short run, though, when you take a step back and look at the longer-term picture, there's a lot to like.
- [By Tom Rojas var popups = dojo.query(".socialByline .popC"); popups.forEach(func]
Cytori Therapeutics Inc.(CYTX) on Tuesday said it is putting a clinical hold on enrollment in two chronic-heart-failure clinical trials, citing safety concerns. Shares sank 32.9% to $1.41 premarket.
No comments:
Post a Comment